ArticleAmerican journal of blood research2021
Blood viscosity of COVID-19 patient: a preliminary report.
Article in American journal of blood research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 46 citations in OpenAlex.
- Hematologic and Computed Tomography Features for Discriminating COVID-19 From Non-COVID-19 Pneumonia.Archives of Razi Institute · 2025Article
- Risk factors for elective and emergency oxygenator exchanges during veno-venous extracorporeal membrane oxygenation.Perfusion · 2024Observational
- Acoustic Waves in Piezoelectric Layered Structure for Selective Detection of Liquid Viscosity.Sensors (Basel, Switzerland) · 2023Article
- Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties.Clinical and experimental medicine · 2023Review
- Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis.Molecular psychiatry · 2023Article
- The interplay of inflammation and coagulation in COVID-19 Patients receiving extracorporeal membrane oxygenation support.Perfusion · 2023Article
- Time-related aortic inflammatory response in severely or critical COVID-19.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Article
- Possible Long-Term Cardiovascular Effects of COVID-19.Current cardiology reviews · 2023Article
- Review
- Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 PandemicJournal of clinical research in pediatric endocrinology · 2022Article
- Transient Fanconi Syndrome in a Child with Acute COVID-19 Infection: Correspondence.Indian journal of pediatrics · 2022Article
- Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates.Computation (Basel, Switzerland) · 2022Article
- Altered central and peripheral haemodynamics during rhythmic handgrip exercise in young adults with SARS-CoV-2.Experimental physiology · 2022Article
- COVID-19 and Recurrent Status Epilepticus.Acta bio-medica : Atenei Parmensis · 2022Article
- Comment on glycated hemoglobin level after emergency COVID-19.Geriatrics & gerontology international · 2022Article
- Letter on the article "Long-COVID: Cognitive deficits (brain fog) and brain lesions in nonhospitalized patients".Presse medicale (Paris, France : 1983) · 2022Article
- Estradiol, Immune-Protective Function and COVID-19: Correspondence.Journal of family & reproductive health · 2022Article
- COVID-19 and Light Chain Amyloidosis: Correspondence.The American journal of medicine · 2022Article
- Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model.EJHaem · 2022Article
- Diabetic ketoacidosis, COVID-19 and blood viscosity.Journal of Taibah University Medical Sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is the important global problem. This new coronavirus can cause several hematological changes. Thrombosis is a problem might occur in COVID-19. In COVID-19, thrombosis might be the result of endothelial dysfunction, platelet activation, increasd blood viscosity, and blood flow disturbance. The change of blood viscosity in the patients with COVID-19 is possible but little mentioned. Here, the authors report on a preliminary data on blood viscosity assessment among 41 COVID-19 patients. According to the estimation, the estimated blood viscosity values are 72.4 ± 18.6 and 18.2 ± 2.2 for high and low shear rates. Based on this preliminary report, the increased blood viscosity is detected in COVID-19 patient and it might be associated with thrombohemostatic problem.
Indexed as
Identifiers
33796395PMC8010604W3147135034What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.